It appears you have not yet Signed Up with our community. To Sign Up for free, please click here....

Reflex Sympathetic Dystrophy (RSD) (CRPS) Message Board

Reflex Sympathetic Dystrophy (RSD) (CRPS) Board Index

Pregabalin (Lyrica)
Nov 17, 2004
I was reading this board and saw Neurontin pop up several times. Just wanted to let people know that Lyrica (Pregabalin) has replaced Neurontin. It's new from Pfizer and suppose to be much better.
hey thanks for posting about the new med, but i can not find anyithng about it being out on the market yet. I have tried all the major pharm. sites and they dont even list it on there lists. And even on the drug manuf. site it doesnt say that its available yet.?? Have you gotten this med?? Im very interested in this bc it was made for Neuropathic pain, and the neurontin i am on is not workin. Hope to hear back from you!! Thx!!
RSDAngel, sorry to hear about your pain. I've been following Pregablin (Lyrica) for a while, I believe the FDA gave it the go ahead a couple months ago for nerve pain. Perhaps the pharmacies don't have it listed yet since it's so new. You might need to call them.

Here is what I found recently from the PRNEWSWIRE

Q31) What is the status of Lyrica (pregabalin)?

A31) Lyrica is Pfizer's drug candidate for a range of neurological
disorders. In July, Lyrica received marketing authorization in the
E.U. for management of peripheral neuropathic pain and as an
adjunctive therapy in the treatment of partial seizures in patients
with epilepsy. By September, Pfizer had launched Lyrica in the U.K.
and Germany, with launches in other E.U. member states scheduled for
the rest of 2004 and 2005.

In the U.S., Pfizer recently received approvable letters from the FDA
in September for treatment of neuropathic pain associated with
diabetic peripheral neuropathy and postherpetic neuralgia, and as
adjunctive therapy in the treatment of partial seizures in adults.
Pfizer received a non-approvable letter for the treatment of
generalized anxiety disorder. We continue to work closely with the
FDA to resolve open issues on all indications and labeling.

As published data attest, Lyrica has demonstrated consistent,
significant pain reduction. Lyrica also consistently reduced
seizures within the first week as adjunctive therapy for epilepsy.
The therapeutic effects of Lyrica are sustained over time across
indications. Lyrica was the subject of one of the largest clinical
development programs ever to support a regulatory filing for a
central-nervous-system compound, including more than 9,000 patients.
I asked at my pharm and they said that it's generally 6-8 months after a new drug has hit the market that the pharm's start seeing it regularly. They could special order it if my doc wrote a presc for it, but might not get it very soon. I'm sure Pfizer would have a distro list to see what States have recieved it already though.

All times are GMT -7. The time now is 10:37 AM.

© 2020 MH Sub I, LLC dba Internet Brands. All rights reserved.
Do not copy or redistribute in any form!